BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26135889)

  • 1. Myeloid Sirtuin 2 Expression Does Not Impact Long-Term Mycobacterium tuberculosis Control.
    Cardoso F; Castro F; Moreira-Teixeira L; Sousa J; Torrado E; Silvestre R; Castro AG; Saraiva M; Pais TF
    PLoS One; 2015; 10(7):e0131904. PubMed ID: 26135889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CISH controls bacterial burden early after infection with Mycobacterium tuberculosis in mice.
    Carow B; Gao Y; Terán G; Yang XO; Dong C; Yoshimura A; Rottenberg ME
    Tuberculosis (Edinb); 2017 Dec; 107():175-180. PubMed ID: 29050767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
    Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
    J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of Roquin Function in Myeloid Cells Reduces
    Nagalingam G; Vinuesa CG; Britton WJ; Saunders BM
    J Immunol; 2017 Sep; 199(5):1796-1804. PubMed ID: 28747346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.
    Happel KI; Lockhart EA; Mason CM; Porretta E; Keoshkerian E; Odden AR; Nelson S; Ramsay AJ
    Infect Immun; 2005 Sep; 73(9):5782-8. PubMed ID: 16113296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT3 Represses Nitric Oxide Synthesis in Human Macrophages upon Mycobacterium tuberculosis Infection.
    Queval CJ; Song OR; Deboosère N; Delorme V; Debrie AS; Iantomasi R; Veyron-Churlet R; Jouny S; Redhage K; Deloison G; Baulard A; Chamaillard M; Locht C; Brodin P
    Sci Rep; 2016 Jul; 6():29297. PubMed ID: 27384401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.
    Fremond CM; Yeremeev V; Nicolle DM; Jacobs M; Quesniaux VF; Ryffel B
    J Clin Invest; 2004 Dec; 114(12):1790-9. PubMed ID: 15599404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18.
    Kawakami K; Kinjo Y; Uezu K; Miyagi K; Kinjo T; Yara S; Koguchi Y; Miyazato A; Shibuya K; Iwakura Y; Takeda K; Akira S; Saito A
    Microbes Infect; 2004 Apr; 6(4):339-49. PubMed ID: 15050961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells.
    Richardson ET; Shukla S; Sweet DR; Wearsch PA; Tsichlis PN; Boom WH; Harding CV
    Infect Immun; 2015 Jun; 83(6):2242-54. PubMed ID: 25776754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
    Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
    PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.
    Bai X; Shang S; Henao-Tamayo M; Basaraba RJ; Ovrutsky AR; Matsuda JL; Takeda K; Chan MM; Dakhama A; Kinney WH; Trostel J; Bai A; Honda JR; Achcar R; Hartney J; Joosten LA; Kim SH; Orme I; Dinarello CA; Ordway DJ; Chan ED
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):5111-6. PubMed ID: 25820174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid HIF-1α regulates pulmonary inflammation during experimental Mycobacterium tuberculosis infection.
    Resende M; Ferreira CM; Barbosa AM; Cardoso MS; Sousa J; Saraiva M; Castro AG; Appelberg R; Torrado E
    Immunology; 2020 Jan; 159(1):121-129. PubMed ID: 31606895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired M. tuberculosis Antigen-Specific IFN-γ Response without IL-17 Enhancement in Patients with Severe Cavitary Pulmonary Tuberculosis.
    Fan L; Xiao H; Mai G; Su B; Ernst J; Hu Z
    PLoS One; 2015; 10(5):e0127087. PubMed ID: 26018190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection.
    Allie N; Grivennikov SI; Keeton R; Hsu NJ; Bourigault ML; Court N; Fremond C; Yeremeev V; Shebzukhov Y; Ryffel B; Nedospasov SA; Quesniaux VF; Jacobs M
    Sci Rep; 2013; 3():1809. PubMed ID: 23657146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis.
    Rojas-López AE; Soldevila G; Meza-Pérez S; Dupont G; Ostoa-Saloma P; Wurbel MA; Ventura-Juárez J; Flores-Romo L; García-Zepeda EA
    Immunobiology; 2012 Aug; 217(8):795-807. PubMed ID: 22633147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.
    Lazarevic V; Yankura DJ; DiVito SJ; Flynn JL
    Infect Immun; 2005 May; 73(5):2910-22. PubMed ID: 15845497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
    Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
    Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of Mycobacterium tuberculosis whiB3 in the mouse lung and macrophages.
    Banaiee N; Jacobs WR; Ernst JD
    Infect Immun; 2006 Nov; 74(11):6449-57. PubMed ID: 16923787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLS/IL-12-modified Mycobacterium smegmatis as a novel anti-tuberculosis immunotherapeutic vaccine.
    Yang C; He YL; Zhang L; Xu L; Yi Z; Wang Y; Li N; Zhu D
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1360-6. PubMed ID: 19861007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
    Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
    J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.